PSI Advisors »

Syros Pharmaceuticals shares owned by PSI Advisors

Quarter-by-quarter ownership of Syros Pharmaceuticals (SYRS) shares owned by PSI Advisors from 13F filings

Historical chart of PSI Advisors investment in Syros Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syros Pharmaceuticals held by PSI Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syros Pharmaceuticals by PSI Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $69 13 5.38
2023-12-31 $100 13 7.77

More positions owned by PSI Advisors

Spdr Portfolio S&p 500 Uit Exchange Traded (SPLG)
Invsc Qqq Trust Srs 1 Uit Exchange Traded (QQQ)
Ishares Core MF Closed and MF Open (DGRO)
First Trust MF Closed and MF Open (BUFR)
Jp Morgan MF Closed and MF Open (JEPQ)
Spdr Portfolio S&p 400 Uit Exchange Traded (SPMD)
Pacer Us Cash Cows 100 Uit Exchange Traded (COWZ)
First Trust MF Closed and MF Open (KNG)
Spdr Portfolio S&p 600 Uit Exchange Traded (SPSM)
Apple Common Stock (AAPL)
Select Sector MF Closed and MF Open (XLRE)
First Trust MF Closed and MF Open (SDVY)
Invesco S&p MF Closed and MF Open (XMHQ)
Energy Transfer Limited Partnershp (ET)
Spdr S&p 500 Growth Etf Uit Exchange Traded (SPYG)

View all positions for PSI Advisors

Top funds holding Syros Pharmaceuticals

Artal Group
Adage Capital Partners GP
Samsara BioCapital
Avidity Partners Management
Blue Owl Capital Holdings
Point72 Asset Management
Flagship Ventures Management
Vanguard Group
Kennedy Capital Management
Opaleye Management
Walleye Trading Advisors
BlackRock
Omega Fund Management
Goldman Sachs Group
Geode Capital Management

View all funds holding Syros Pharmaceuticals